By showing that patients with DM on insulin therapy did worse compared with other groups of patients, these findings may have implications with respect to the decision-making and a personalized approach in selecting the most appropriate revascularization strategy in diabetic patients with LMCA disease. The gene discussed is INS; the disease is diabetes mellitus.